Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus. - Wikidata - wikimedia - TriplyDB

Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus.

Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus.

http://www.wikidata.org/entity/Q35141244

about

Systemic antibiotic therapy for chronic osteomyelitis in adults Factors predictive of treatment failure in staphylococcal prosthetic vascular graft infections: a prospective observational cohort study: impact of rifampin.Predisposing factors for recurrence of chronic posttraumatic osteomyelitis: a retrospective observational cohort study from a tertiary referral center in Brazil.Common changes in global gene expression induced by RNA polymerase inhibitors in Shigella flexneri Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Improved outcome with early rifampicin combination treatment in methicillin-sensitive Staphylococcus aureus bacteraemia with a deep infection focus - a retrospective cohort study Outcome of patients with streptococcal prosthetic joint infections with special reference to rifampicin combinations.Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.Outcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapy Success after treatment of periprosthetic joint infection: a Delphi-based international multidisciplinary consensus.Prosthesis infections after orthopedic joint replacement: the possible role of bacterial biofilms Vancomycin-rifampin combination therapy has enhanced efficacy against an experimental Staphylococcus aureus prosthetic joint infection.Polymeric nanofiber coating with tunable combinatorial antibiotic delivery prevents biofilm-associated infection in vivo Antimicrobial-related severe adverse events during treatment of bone and joint infection due to methicillin-susceptible Staphylococcus aureus.Periprosthetic joint infection--effect on quality of life Current pharmacotherapy options for osteomyelitis: convergences, divergences and lessons to be drawn.Current concepts in the management of prosthetic joint infection.Staphylococcus aureus chronic and relapsing infections: Evidence of a role for persister cells: An investigation of persister cells, their formation and their role in S. aureus disease.A Retrospective Review of the Clinical Experience of Linezolid with or Without Rifampicin in Prosthetic Joint Infections Treated with Debridement and Implant Retention.An update on surgical and antimicrobial therapy for acute periprosthetic joint infection: new challenges for the present and the future.Is prosthesis retention effective for chronic infections in hip arthroplasties? A systematic literature review.Influence of daily dosage and frequency of administration of rifampicin-levofloxacin therapy on tolerance and effectiveness in 154 patients treated for prosthetic joint infections.Microbiological Diagnosis of Implant-Related Infections: Scientific Evidence and Cost/Benefit Analysis of Routine Antibiofilm Processing.Population pharmacokinetics of rifampicin in adult patients with osteoarticular infections: interaction with fusidic acid.Intracellular Pharmacokinetics of Antibacterials and Their Clinical Implications.New in vitro and in vivo models to evaluate antibiotic efficacy in Staphylococcus aureus prosthetic vascular graft infection.Bacteria antibiotic resistance: New challenges and opportunities for implant-associated orthopedic infections.Infection recurrence factors in one- and two-stage total knee prosthesis exchanges.Good quality of life outcomes after treatment of prosthetic joint infection with debridement and prosthesis retention.Antibacterial effect of antibiotic-loaded SBA-15 on biofilm formation by Staphylococcus aureus and Staphylococcus epidermidis.Importance of selection and duration of antibiotic regimen in prosthetic joint infections treated with debridement and implant retention.Prosthetic knee infection by resistant bacteria: the worst-case scenario.Efficacy of Single-stage Revision with Aggressive Debridement Using Intra-articular Antibiotics in the Treatment of Infected Joint Prosthesis.Predictors of treatment outcome in prosthetic joint infections treated with prosthesis retention.Effectiveness of gentamicin-containing collagen sponges for prevention of surgical site infection after hip arthroplasty: a multicenter randomized trial.Which method is the most effective for preventing postoperative infection in spinal surgery?Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections.Oral antibiotic therapy.Irrigation and debridement.Etiology of surgical site infections after primary total joint arthroplasties.

P2860

Q28714211-5ECA9BA7-CA6B-4180-B485-0E928CC57D31 Q33726771-ABDCB72A-BA87-4B3F-912C-E78D24B1C632 Q33759244-21002153-4C15-49B6-B1AF-E9827E7060B8 Q34200649-CF0F7DB2-C000-49D6-9614-6FF18A5C533A Q34478074-CC066FE6-EB25-4F1D-8A9E-D91D6348FCA3 Q35391386-FF26EFB9-3263-4722-B52A-F82C64143445 Q36163096-C1F102B6-5734-454D-9EC7-E78B657F3964 Q36181397-0EC4F835-7A30-4BD6-B682-1A0E39FA90C9 Q36505327-B4ADCCCD-3C91-4C34-8A5B-1BED10F81D09 Q36912994-408A7453-F591-4839-9F9F-9768B4F2BFDB Q37032050-907CF620-CE22-4CDF-801B-1F6CF331DAE1 Q37263918-4930559C-92FE-4B93-A0D6-1B31AA8DD63B Q37417976-F63EC011-97DA-4A9B-9B0F-D534AB746E82 Q37544629-322A85BF-F4C2-4FDE-9458-E48B64E91197 Q37720136-E377A115-E4C3-4C5B-B8D7-EDC83D11318D Q38089918-0A39A907-9A32-43D7-905A-662D20D739C6 Q38221335-47BC5A4C-EEE9-4F03-AB3C-AD4F0D6F6B55 Q38237595-CECBF163-215D-4110-AD69-CB489982B8B0 Q38241474-F3B1CF4C-7A50-4BCC-939E-E790BC5C249D Q38314400-D3412834-A558-42A3-B450-B7E1192508FD Q38450497-181B91E9-9D28-40F8-AE89-D7037F420AD9 Q38490164-2B8B7594-6906-4415-AFD9-24EB9E5A08B7 Q38999377-253EE2C0-1056-4A56-A1EA-4DC10FCA3639 Q39215691-9386CCF2-E7DC-4197-9D30-4B994FF1A10E Q39390126-79380408-E953-4349-8A26-741891E2E4F4 Q40018152-97F7205C-DE40-4311-B5E7-344BB7976E15 Q40128761-94873F54-2350-406A-B789-ED2BBAB6790C Q40269668-255F6D46-7B92-4112-9B2B-88E691EFA9F9 Q40374830-BD186FF2-CF98-408F-90B9-AE938ED1A2EC Q40401375-428F1768-16C2-47FC-A67C-FA641536C528 Q40772358-E288F883-E939-49F0-BB2F-2EFCFC304820 Q40810078-63C37495-4966-4552-8E97-AA0313422F5F Q41049090-27758507-0632-4CFE-974A-BD6F20A4B87A Q41126065-EBA8D957-3E34-468F-9247-6C0BFBC085B9 Q41303083-6F7AFC00-1041-4285-BC3C-12529E4F2E5A Q41308062-2B944680-E639-4481-B1D4-8B02024CDF26 Q41359629-F23A2F5E-A333-4947-8F53-25DE66B2AB04 Q42231206-9D2A84C6-4FE4-4F52-8C50-EC01003EF913 Q42231216-6C67AF45-EBA5-4309-829E-9224BFEAFBC6 Q42232531-CFA8EBB2-D2D6-4DAA-B725-9F8D2F5B1DC3

P2860

Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus.

http://www.wikidata.org/entity/Q35141244

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Outcome and predictors of trea ...... due to Staphylococcus aureus.

@ast

Outcome and predictors of trea ...... due to Staphylococcus aureus.

@en

type

label

Outcome and predictors of trea ...... due to Staphylococcus aureus.

@ast

Outcome and predictors of trea ...... due to Staphylococcus aureus.

@en

prefLabel

Outcome and predictors of trea ...... due to Staphylococcus aureus.

@ast

Outcome and predictors of trea ...... due to Staphylococcus aureus.

@en

P1433

Q35141244-0D1B5659-C192-43A1-B106-705BFF5F27FD

P1476

Q35141244-4EF90F1B-8602-4808-9522-3F3A4151A853

P2093

Q35141244-168774DB-DE68-4F56-86C3-29D8EF682D94

Q35141244-176FED35-10CE-437B-A81C-A01EC12295F2

Q35141244-23D12FD1-FB44-4F09-BDE4-1F27FC41A768

Q35141244-3639C0D3-43D2-4C2B-8677-358CD8D4A2CB

Q35141244-4343F200-1C12-4886-86B6-EBE616F0B8A6

Q35141244-4E3D411E-71CE-484A-9832-61BADFA6F3DC

Q35141244-7D63CC5D-FE6D-43E7-91F8-4945C984630D

Q35141244-9E7AA841-C902-4DF0-A5B2-E38A9E336A97

Q35141244-B20B1EA4-0F23-4A59-8FD9-7BFC85A60190

Q35141244-B665BAC7-7A6C-4AA6-B717-D8F90137F36A

P2860

Q35141244-0EC36602-41FE-49B5-A41A-447BED0ACD43

Q35141244-13C7BCFF-8C68-4CFC-82FB-257053EA819A

Q35141244-155A879C-0D49-42BF-BB4A-BE83851C746C

Q35141244-16AF8190-1CAF-4323-867F-A00479D08131

Q35141244-2DC7E014-E5F8-40F0-BC2D-96D2F895A968

Q35141244-2DF32BF4-8F39-4677-9C5B-B39BF3949498

Q35141244-2FD06830-B036-411E-88FD-55EFCE14B773

Q35141244-36960F3B-5F84-4C35-A6F5-2A7396AA57C6

Q35141244-39DAE500-9368-46B7-A067-540738305600

Q35141244-3E630E57-F98A-4D16-BAA0-9BBDFB333E2E

P304

Q35141244-3E0479B8-AFC8-43C3-83BD-B8EC956FB265

P31

Q35141244-DA6B7C92-4387-4C59-8D0C-4519AB91360F

P356

Q35141244-2A712C60-0F8C-46BF-80F6-65E795BA2016

P407

Q35141244-2CFDAE82-98A7-4B48-91FE-713A2D47E9E9

P433

Q35141244-1BC83672-F774-431B-A41E-1927E261D899

P478

Q35141244-6632C158-7874-4D1F-BD4E-BC62A8737B49

P577

Q35141244-E1CE77B3-E2B0-4DC4-9CBD-D6E8BEA049B5

P5875

Q35141244-89E3371E-456C-4BC0-880F-A9A391894D1E

P698

Q35141244-4C11E883-F2ED-4E9B-82B9-2341C6CCB2BF

P932

Q35141244-69DA855E-3A6C-4C2A-AC34-E997B92F3996

P356

P1433

Clinical Infectious Diseases

P1476

Outcome and predictors of trea ...... due to Staphylococcus aureus.

@en

P2093

Bernadette Roselé

http://www.w3.org/2001/XMLSchema#string

Carlos Maynou

http://www.w3.org/2001/XMLSchema#string

Caroline Loïez

http://www.w3.org/2001/XMLSchema#string

Donatienne Joulie

http://www.w3.org/2001/XMLSchema#string

Eric Beltrand

http://www.w3.org/2001/XMLSchema#string

Eric Senneville

http://www.w3.org/2001/XMLSchema#string

Henri Migaud

http://www.w3.org/2001/XMLSchema#string

Hervé Dezèque

http://www.w3.org/2001/XMLSchema#string

Laurence Legout

http://www.w3.org/2001/XMLSchema#string

Michel Valette

http://www.w3.org/2001/XMLSchema#string

P2860

Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole).

Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid.

Prosthetic-joint infections.

Guiding empirical antibiotic therapy in orthopaedics: The microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention.

Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations.

Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones.

Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030

Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants.

Factors influencing the incidence and outcome of infection following total joint arthroplasty.

Two-stage reconstruction of a total hip arthroplasty because of infection.

P304

334-340

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIR402

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51541736

http://www.w3.org/2001/XMLSchema#string

P698

21810745

http://www.w3.org/2001/XMLSchema#string

P932

3148259

http://www.w3.org/2001/XMLSchema#string